![]() |
Name |
asperthrin A
|
Molecular Formula | C26H27N3O4 | |
IUPAC Name* |
9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione
|
|
SMILES |
CC1(C)C=Cc2c(ccc3c2[N+]([O-])=C2C3=CC34NC(=O)C5(CCCN5C3=O)CC4C2(C)C)O1
|
|
InChI |
InChI=1S/C26H27N3O4/c1-23(2)10-8-15-17(33-23)7-6-14-16-12-26-18(24(3,4)20(16)29(32)19(14)15)13-25(21(30)27-26)9-5-11-28(25)22(26)31/h6-8,10,12,18H,5,9,11,13H2,1-4H3,(H,27,30)/t18-,25+,26?/m0/s1
|
|
InChIKey |
ALXLLOQTGLPCFG-BHSDOMOJSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 445.52 | ALogp: | 3.1 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 84.7 | Aromatic Rings: | 8 |
Heavy Atoms: | 33 | QED Weighted: | 0.485 |
Caco-2 Permeability: | -4.927 | MDCK Permeability: | 0.00002430 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.067 | 20% Bioavailability (F20%): | 0.149 |
30% Bioavailability (F30%): | 0.015 |
Blood-Brain-Barrier Penetration (BBB): | 0.395 | Plasma Protein Binding (PPB): | 92.71% |
Volume Distribution (VD): | 1.645 | Fu: | 5.66% |
CYP1A2-inhibitor: | 0.065 | CYP1A2-substrate: | 0.782 |
CYP2C19-inhibitor: | 0.684 | CYP2C19-substrate: | 0.905 |
CYP2C9-inhibitor: | 0.877 | CYP2C9-substrate: | 0.711 |
CYP2D6-inhibitor: | 0.742 | CYP2D6-substrate: | 0.113 |
CYP3A4-inhibitor: | 0.939 | CYP3A4-substrate: | 0.937 |
Clearance (CL): | 1.125 | Half-life (T1/2): | 0.133 |
hERG Blockers: | 0.28 | Human Hepatotoxicity (H-HT): | 0.93 |
Drug-inuced Liver Injury (DILI): | 0.274 | AMES Toxicity: | 0.085 |
Rat Oral Acute Toxicity: | 0.815 | Maximum Recommended Daily Dose: | 0.898 |
Skin Sensitization: | 0.035 | Carcinogencity: | 0.975 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.347 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004943 | ![]() |
0.646 | D06XZW | ![]() |
0.211 | ||
ENC004944 | ![]() |
0.619 | D06YFA | ![]() |
0.206 | ||
ENC004945 | ![]() |
0.619 | D06HBQ | ![]() |
0.204 | ||
ENC002704 | ![]() |
0.586 | D0U3SY | ![]() |
0.204 | ||
ENC004948 | ![]() |
0.586 | D0C7JF | ![]() |
0.203 | ||
ENC003383 | ![]() |
0.586 | D01TSI | ![]() |
0.201 | ||
ENC005468 | ![]() |
0.573 | D0N0RU | ![]() |
0.200 | ||
ENC004072 | ![]() |
0.562 | D02JNM | ![]() |
0.200 | ||
ENC002534 | ![]() |
0.559 | D0V4WD | ![]() |
0.199 | ||
ENC002366 | ![]() |
0.559 | D05MQK | ![]() |
0.197 |